BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 22125446)

  • 1. Interaction between α-synuclein and other proteins in neurodegenerative disorders.
    Jellinger KA
    ScientificWorldJournal; 2011; 11():1893-907. PubMed ID: 22125446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between pathogenic proteins in neurodegenerative disorders.
    Jellinger KA
    J Cell Mol Med; 2012 Jun; 16(6):1166-83. PubMed ID: 22176890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
    Melki R
    J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
    Yan X; Uronen RL; Huttunen HJ
    Semin Cell Dev Biol; 2020 Mar; 99():55-64. PubMed ID: 29738880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
    Gadad BS; Britton GB; Rao KS
    J Alzheimers Dis; 2011; 24 Suppl 2():223-32. PubMed ID: 21460436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.
    Li X; James S; Lei P
    J Mol Neurosci; 2016 Nov; 60(3):298-304. PubMed ID: 27629562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Tau, β Amyloid and α-Synuclein Pathologies.
    Walker L; Attems J
    Adv Exp Med Biol; 2019; 1184():169-176. PubMed ID: 32096037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein and tau: teammates in neurodegeneration?
    Moussaud S; Jones DR; Moussaud-Lamodière EL; Delenclos M; Ross OA; McLean PJ
    Mol Neurodegener; 2014 Oct; 9():43. PubMed ID: 25352339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
    Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
    J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
    Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
    Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of proteins in neurodegenerative disease].
    Szwed A; Miłowska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.
    Duyckaerts C; Seilhean D; Sazdovitch V; Plu I; Delatour B; Potier MC
    Bull Acad Natl Med; 2015 Jun; 199(6):809-819. PubMed ID: 29901881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
    Lee VM; Giasson BI; Trojanowski JQ
    Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology of basal ganglia in neurodegenerative diseases].
    Wakabayashi K; Tanji K; Mori F
    Brain Nerve; 2009 Apr; 61(4):429-39. PubMed ID: 19378813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration.
    Ciaccioli G; Martins A; Rodrigues C; Vieira H; Calado P
    PLoS One; 2013; 8(2):e55848. PubMed ID: 23393603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases.
    Nelson PT; Abner EL; Patel E; Anderson S; Wilcock DM; Kryscio RJ; Van Eldik LJ; Jicha GA; Gal Z; Nelson RS; Nelson BG; Gal J; Azam MT; Fardo DW; Cykowski MD
    J Neuropathol Exp Neurol; 2018 Jan; 77(1):2-20. PubMed ID: 29186501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
    Goedert M; Masuda-Suzukake M; Falcon B
    Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-to-Cell Transmission of Tau and α-Synuclein.
    Uemura N; Uemura MT; Luk KC; Lee VM; Trojanowski JQ
    Trends Mol Med; 2020 Oct; 26(10):936-952. PubMed ID: 32371172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding realm of prion phenomena in neurodegenerative disease.
    Frost B; Diamond MI
    Prion; 2009; 3(2):74-7. PubMed ID: 19448400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.